Actinogen Medical Applies for New ASX Quotation
Company Announcements

Actinogen Medical Applies for New ASX Quotation

Actinogen Medical Limited (AU:ACW) has released an update.

Actinogen Medical Limited has announced the application for quotation of new securities on the ASX, with a total of 2,976,534 ordinary fully paid shares to be quoted as of July 4, 2024. The company’s submission adheres to the ASX Listing Rules as it seeks to enhance its financial strength and market presence.

For further insights into AU:ACW stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskActinogen Medical’s Xanamem Shows Antidepressant Promise
TipRanks Australian Auto-Generated NewsdeskActinogen’s Xanamem Shows Promise in Depression
TipRanks Australian Auto-Generated NewsdeskActinogen Medical Awaits Clinical Trial Results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!